{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,4]],"date-time":"2026-10-04T04:07:12Z","timestamp":1791086832841,"version":"4.1.0"},"reference-count":19,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T00:00:00Z","timestamp":1235001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Develop Med Child Neuro"],"published-print":{"date-parts":[[2009,3]]},"abstract":"<jats:p>Cerebral folate deficiency (CFD) is associated with low levels of 5\u2010methyltetrahydrofolate in the cerebrospinal fluid (CSF) with normal folate levels in the plasma and red blood cells. The onset of symptoms caused by the deficiency of folates in the brain is at around 4 to 6 months of age. This is followed by delayed development, with deceleration of head growth, hypotonia, and ataxia, followed in one\u2010third of children by dyskinesias (choreo\u2010athetosis, hemiballismus), spasticity, speech difficulties, and epilepsy.<\/jats:p><jats:p>The low level of 5\u2010methyltetrahydrofolate in the CSF can result from decreased transport across the blood\u2013brain barrier, which is most probably because of the blocking of folate transport into the CSF by the binding of folate receptor antibodies to the folate receptors in the choroid plexus.<\/jats:p><jats:p>Treatment of the condition with folinic acid for prolonged periods can result in significant improvement of clinical symptoms and a return of 5\u2010methyltetrahydrofolate levels in the CSF to normal. In view of this response to treatment in CFD and allied conditions, a case can be made for screening the CSF of patients with neurological disorders of unknown origin.<\/jats:p>","DOI":"10.1111\/j.1469-8749.2008.03185.x","type":"journal-article","created":{"date-parts":[[2009,2,19]],"date-time":"2009-02-19T16:02:01Z","timestamp":1235059321000},"page":"180-182","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":51,"title":["Cerebral folate deficiency"],"prefix":"10.1111","volume":"51","author":[{"given":"NEIL","family":"GORDON","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2009,2,19]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1161\/01.STR.0000153008.60517.ab","article-title":"Folate deficiency increases postischemic brain injury","volume":"36","author":"Endres M","year":"2005","journal-title":"Stroke"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.pediatrneurol.2007.09.001"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2002-37082"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1002\/1097-0142(197602)37:2<853::AID-CNCR2820370234>3.0.CO;2-Q"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.ymgme.2004.12.001"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2008.02053.x"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1469-8749.2004.tb00451.x"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1620\/tjem.211.95"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa043160"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0969-9961(03)00070-6"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1097\/00001756-200507130-00005"},{"key":"e_1_2_6_13_2","doi-asserted-by":"publisher","DOI":"10.1212\/01.wnl.0000309223.98616.e4"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1177\/0883073807307986"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991148"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2008-1065354"},{"key":"e_1_2_6_17_2","first-page":"171","article-title":"Relapsing neuropathy, cerebral atrophy and folate deficiency","volume":"42","author":"Botez MI","year":"1979","journal-title":"Appl Neurophysiol"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1157\/13090262"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1002\/ana.20746"},{"key":"e_1_2_6_20_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-2007-991150"}],"container-title":["Developmental Medicine &amp; Child Neurology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fj.1469-8749.2008.03185.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/j.1469-8749.2008.03185.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,9,29]],"date-time":"2023-09-29T01:35:59Z","timestamp":1695951359000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/j.1469-8749.2008.03185.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,2,19]]},"references-count":19,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2009,3]]}},"alternative-id":["10.1111\/j.1469-8749.2008.03185.x"],"URL":"https:\/\/doi.org\/10.1111\/j.1469-8749.2008.03185.x","archive":["Portico"],"relation":{},"ISSN":["0012-1622","1469-8749"],"issn-type":[{"value":"0012-1622","type":"print"},{"value":"1469-8749","type":"electronic"}],"subject":[],"published":{"date-parts":[[2009,2,19]]},"assertion":[{"value":"2009-02-19","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}